Target intelligence / Profile preview

Rho GTPase-activating protein 10 (ARHGAP10)

Target
ARHGAP10
Molecular classification
Enzyme, Rho GTPase-activating protein, Signal transduction regulator
01

Overview

Rho GTPase-activating protein 10 (ARHGAP10) is an enzyme that regulates signaling cascades by promoting the hydrolysis of GTP bound to Rho family GTPases, converting them from their active (GTP-bound) to inactive (GDP-bound) states. This action suppresses Rho GTPase-mediated processes, influencing actin cytoskeleton dynamics, cell adhesion, and migration. ARHGAP10 contains multiple domains, including BAR, PH, RhoGAP, and SH3, enabling it to perform modular regulatory functions. The gene exhibits alternative splicing, producing variants with context-specific effects. Reduced ARHGAP10 expression has been observed in breast tumor tissue and is associated with advanced cancer stage and poor prognosis, suggesting a tumor suppressor role. Additionally, it participates in apoptosis regulation, and genetic variants are linked to schizophrenia and other neuropsychiatric conditions.

Other names
GRAF2PSGAPPS-GAPFLJ20896FLJ41791GTPase regulator associated with focal adhesion kinase 2Graf-related protein 2RHG10_HUMAN
02

Biological functions

Cytoskeleton organizationNegative regulation of apoptotic processSignal transductionCell adhesionCell migration
03

Disease associations

Cancer (notably breast cancer and potentially other types due to its regulatory role in cytoskeleton and migration signaling)Lung non-small cell carcinomaSchizophrenia (associated variant)Other neurological or developmental pathways
04

Biomarkers

ARHGAP10 downregulation has been linked to advanced clinical stage and poorer relapse-free survival in breast cancer

Beyond the preview

Go deeper on Rho GTPase-activating protein 10 (ARHGAP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho GTPase-activating protein 10 (ARHGAP10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call